Close Menu

NEW YORK (GenomeWeb) – MDxHealth today announced it has licensed its methylation-specific PCR technology to molecular diagnostics firm Oncgnostics for use in a cervical cancer test.

The agreement grants Jena, Germany-based Oncgnostics a limited, non-transferable, non-exclusive, worldwide license for diagnostic applications in cervical cancer.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.

A WHO panel is calling for a global registry of human germline gene-editing projects, according to Stat News.

Vox writes that lab mishaps involving pathogens are quite common.

In Genome Biology this week: analysis of wild and cultivated peach genomes, Hi-C-based pipeline for assembling microbial genomes from metagenomic data, and more.